top of page
Search

Apr 02, 2021

Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated New Drug Application for Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil) in 118.28 mL bottle a generic version of reference listed drug DERMA-SMOOTHE/FS. For more updates, please visit the products page or email us directly at info@solaris-pharma.com

96 views0 comments

Recent Posts

See All

Solaris Pharma Corporation is pleased to announce the product approval of Tazarotene Gel, 0.05% and 0.1%.

Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated New Drug Application for Clindamycin Phosphate Gel USP

bottom of page